Ligand-induced trafficking plays an important role in the physiologic regulation of many G protein-coupled receptors (GPCRs). Although numerous GPCRs are sorted to a degradative pathway upon prolonged stimulation, the molecular events leading to degradation are poorly understood. Here we report that the HIV co-receptor CXCR4 undergoes rapid agonistpromoted degradation by a process involving endocytosis via clathrin coated pits and subsequent sorting to lysosomes. Studies analyzing the sorting of various CXCR4 mutants revealed the presence of a degradation motif (SSLKILSKGK) in the carboxyl terminus of CXCR4. The first two serines as well as the dileucine motif were critical for agonist-induced endocytosis, whereas all three serines but not the dileucine were important in mediating degradation. Mutation of the three lysine residues had no effect on CXCR4 endocytosis yet completely inhibited receptor degradation. Because lysine residues represent potential sites of ubiquitination, we also examined the ubiquitination of CXCR4. Interestingly, CXCR4 was shown to undergo rapid agonist-promoted ubiquitination that was attenuated by mutation of the lysine residues within the degradation motif. These studies implicate a specific role for ubiquitination in sorting endocytosed GPCRs to lysosomes.
INTRODUCTION
A common feature among G protein-coupled receptor (GPCR) signaling systems is desensitization, the loss of responsiveness of a receptor when subjected to continuous stimulation. Studies into the mechanisms involved in this process have revealed that G proteincoupled receptor kinases (GRKs) and arrestins are important regulators of GPCR desensitization (1, 2) . Upon agonist exposure, many GPCRs are rapidly phosphorylated by a GRK, resulting in binding of arrestin which serves to both uncouple the receptor from G protein and initiate GPCR endocytosis. Non-visual arrestins have been shown to act as adaptor molecules in agonist mediated endocytosis of GPCRs by interacting with clathrin (3), AP2 (4), and phosphoinositides (5) , thereby directing the receptor into clathrin coated pits where it undergoes subsequent endocytosis. Once internalized, some GPCRs are dephosphorylated and subsequently recycled back to the plasma membrane where they can again respond to agonist, a process termed resensitization (6) .
Although many GPCRs undergo this process of endocytosis and recycling, prolonged or chronic agonist stimulation can also lead to a significant decrease in the total cellular complement of a given GPCR, a process termed down-regulation (7) . The principal mechanism underlying down-regulation is GPCR degradation, a multi-step process often involving endocytosis and subsequent delivery of the receptor to lysosomes for proteolysis (7) . Despite the prevalence of this phenomenon among GPCRs relatively little is known about the molecular mechanisms involved in sorting GPCRs to lysosomes.
The chemokine receptors CXCR4 and CCR5 represent particularly interesting models for analysis of GPCR endocytosis and sorting because expression and trafficking of these receptors are known to be critical to HIV infection (8, 9) . CCR5 undergoes rapid agonist-promoted endocytosis and recycling (10) whereas CXCR4 is also subject to rapid agonist-promoted endocytosis but appears to be poorly recycled (9, 11) . Moreover, Tarasova et al. have demonstrated that a CXCR4-GFP chimera undergoes agonist-dependent localization in lysosomes (11) . Here, we use CXCR4 as a model to define mechanisms mediating the sorting of GPCRs to lysosomes.
EXERIMENTAL PROCEDURES
DNA constructs. HA-tagged CXCR4 in the vector pcDNA3 was generated by polymerase chain reaction (PCR) using HA-tagged CXCR4 in the vector pSR1 as a template. A ubiquitin construct containing three consecutive FLAG epitopes at the amino terminus (3×FLAG-Ub) was generated by PCR using His 6 Myc-tagged ubiquitin as a template followed by subcloning into the vector p3×FLAG-CM-10 (Sigma). All constructs were sequenced to verify that no errors were introduced by PCR.
Analysis of CXCR4 degradation by immunoblotting. CEM cells (2.4 × 10 6 ) (American Type
Culture Collection) were initially incubated in RPMI 1640 media with 10% FBS containing 5 µg/ml cycloheximide for 15 min at 37 o C. Cells were then incubated in the same media for 6 hr at 37 o C in the presence of 100 nM SDF-1α for 0, 1, 3 or 6 hr of the incubation. Cells were lysed by addition of SDS sample buffer and sonication and proteins were resolved by SDS-PAGE and transblotted onto nitrocellulose. Blots were incubated with an anti-CXCR4 4 by guest on November 6, 2017 http://www.jbc.org/ Downloaded from monoclonal antibody (12) and analyzed by chemiluminescence (Pierce) as previously described (13) . Blots were then stripped and probed using β-tubulin primary antibodies (Accurate). Films were scanned and normalized for total protein using the β-tubulin blots (which varied <1.2-fold per experiment).
HEK 293 cells grown to 60 to 80% confluency in 6 cm dishes were transfected with 3 µg of pcDNA3-HA-CXCR4 DNA. The next day cells were split into 24 well plates coated with 0.1 mg/ml poly-L-lysine and allowed to grow for a further 24 hr. Cells were then treated and analyzed as described above for CEM cells.
Analysis of CXCR4 degradation by radioligand binding. Binding assays were performed using a procedure similar to that described previously (14) . CEM cells (6 × 10 5 cells/ml) were incubated in complete media containing 5 µg/ml cycloheximide for 15 min and then treated with 100 nM SDF-1α for 3 hr. Membranes, prepared as described (14) , were incubated with ~50 pM [ 125 I]-SDF-1α (NEN) supplemented with unlabeled SDF-1α to a final concentration of 20 nM in binding buffer containing 0.25% bovine serum albumin. Samples were incubated for 1 hr at room temperature with shaking. Reactions were terminated by vacuum filtration through glass fiber filters (presoaked in 1% polyethylenimine) and repeated washes with ice-cold buffer (50 mM Hepes, pH 7.4, 500 mM NaCl). Nonspecific binding was measured in the presence of 1 µM SDF-1α. Bound radioactivity was determined by counting the filters in a gamma counter and results were analyzed using GraphPad Prism software. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and treated with denaturation solution (62.5 mM Tris-HCl, pH 6.7, 100 mM β-mercaptoethanol, 2% SDS) for 30 min at 60 o C (to enhance protein denaturation), and washed with Tris buffered saline containing 0.05% Tween-20. Blots were then incubated with the M2 monoclonal anti-FLAG antibody (1:1000) (Sigma) and processed as described (13) .
Assay of receptor internalization. Internalization of HA-CXCR4 transiently expressed in HEK 293 cells was determined using an ELISA that measures the level of epitope-tagged cell surface receptors, as described previously (15) . Immunofluoresence microscopy was performed using a method similar to that described previously (16) .
RESULTS AND DISCUSSION
Numerous studies have demonstrated that CXCR4 undergoes rapid endocytosis upon stimulation by its agonist stromal derived factor-1α (SDF-1α) (9, 11, 15, (17) (18) (19) . Mechanistic insight into this process suggests that agonist-promoted endocytosis of CXCR4 is mediated by GRKs and arrestins and occurs via clathrin-coated pits (15, 18, 19) . Because relatively little is known about the fate of endocytosed CXCR4, we assessed whether endogenous CXCR4 in the human T cell lymphoblastoid cell line CEM undergoes agonist-promoted degradation. CEM cells were treated with SDF-1α for 0-6 hr, washed, lysed and analyzed by immunoblotting using an anti-CXCR4 monoclonal antibody. CXCR4 exhibited significant degradation following a 3 or 6 hr exposure to SDF-1α (Figs. 1A and B) . The loss of CXCR4 immunoreactivity also correlated with a loss of receptor binding sites following a 3 hr treatment with agonist as assessed using radiolabeled SDF-1α (Fig. 1C) . Thus, endogenous CXCR4 undergoes rapid and extensive agonist-promoted degradation in CEM cells. In an effort to develop a model system for examining mechanisms of CXCR4 degradation, we tested whether transiently expressed HA-tagged CXCR4 undergoes agonist-promoted degradation in HEK 293 cells. Immunoblot analyses reveal that HA-tagged CXCR4 is rapidly degraded in HEK 293 cells following agonist treatment (Fig. 1D) .
Two major sites in the cell where proteins are degraded are the lysosome and the proteasome.
In order to identify the compartment in which CXCR4 is degraded we used selective inhibitors of lysosomal and proteasomal function. CXCR4 degradation was efficiently inhibited by the lysosomotrophic agent chloroquine in both CEM and HEK 293 cells ( Fig. 2A) . In contrast, CXCR4 degradation was not inhibited by the proteasomal inhibitor MG132 in either cell type (Fig. 2B) . Consistent with these results, we found that agonist treatment promotes CXCR4 colocalization with the late endosome/lysosome marker LAMP1 in HEK 293 cells (Fig. 2C) . Thus, our data suggest that CXCR4 is sorted to and degraded in lysosomes following agonist treatment of CEM and HEK 293 cells.
To define regions of CXCR4 involved in degradation we initially generated chimeras with CCR5, a related chemokine receptor known to be endocytosed and efficiently recycled (10).
Although CCR5 was not degraded, a CCR5 chimera containing the C-terminus of CXCR4 was efficiently degraded upon agonist activation in HEK 293 cells, suggesting that the C-terminal tail of CXCR4 contains the necessary determinants for mediating degradation (data not shown).
Analyses of C-terminal deletion mutants of CXCR4 suggested a discrete region in the Cterminus ( 324 SSLKILSKGK 333 ) contributed to degradation (data not shown). To determine the specific residues mediating degradation we generated receptors with specific mutations within this putative "degradation" motif (summarized in Fig. 3A) . We have previously shown that mutation of the "dileucine" motif (I328A/L329A) or the two N-terminal serine residues (S324A/S325A) within this region resulted in impaired internalization, whereas a serine 330 mutation (S330A) internalized normally (ref. 16 and Fig. 3B ). We next examined whether these receptor mutants are degraded. The serine mutants were significantly attenuated in their ability to be degraded while degradation of the dileucine mutant was similar to that of wild type CXCR4 (Fig. 3C) . Since internalization of the dileucine mutant is only ~40% that of wild type CXCR4, these results demonstrate that the rate limiting step in CXCR4 degradation is the sorting to lysosomes, not internalization. Interestingly, the S330A mutant, which undergoes normal agonist-promoted internalization, is significantly attenuated in degradation suggesting that it is defective in a subsequent sorting step (Fig. 3C) . Similarly, the S324A/S325A mutant, which internalizes to the same extent as the dileucine mutant, appears to be completely defective in its ability to be degraded (Fig. 3C) . These results suggest a role for serines 324, 325, and 330 in the subsequent sorting of internalized CXCR4 to lysosomes.
Ubiquitination, a process involving the covalent attachment of ubiquitin molecules to lysine residues (20) , has been shown to be important in the lysosomal degradation of several plasma membrane proteins (21) . We therefore examined the role of the lysine residues within the "degradation" motif in mediating CXCR4 degradation. A CXCR4 mutant with all three lysine residues changed to arginines internalized similarly to wild-type CXCR4 (Fig. 3B) . In striking contrast, this receptor mutant was completely attenuated in agonist-promoted degradation (Fig.   3C ).
Because the lysine residues within the degradation motif clearly contribute to CXCR4 degradation, we next examined whether CXCR4 is ubiquitinated upon activation. HEK 293 cells were co-transfected with HA-tagged CXCR4 and FLAG-tagged ubiquitin, along with dynamin-1 K44A (which inhibits CXCR4 endocytosis and degradation, data not shown). Cells were treated with agonist for 30 min, then CXCR4 was immunoprecipitated using HA polyclonal antibodies and immunoblotted using a monoclonal antibody specific for the FLAG epitope. As shown in Fig. 4A , an ~54 kDa protein is observed in immunoprecipitates from cells expressing both receptor and ubiquitin, but not observed in cells expressing receptor or ubiquitin alone.
Moreover, the intensity of this band is significantly increased (typically 2-3 fold) by agonist treatment, strongly suggesting that the ~54 kDa protein represents ubiquitinated CXCR4. The size of this protein relative to unmodified CXCR4 (~44 kDa, Fig. 4A, lower panel) , suggests a single ubiquitin molecule conjugated to the receptor (the ubiquitin construct used encodes an 11 kDa protein). To determine whether the lysine residues located within the "degradation" motif are sites for ubiquitination we tested whether the mutant receptor lacking all three lysine residues undergoes ubiquitination. This mutant was not ubiquitinated upon agonist activation indicating that these lysine residues represent sites at which ubiquitin can be attached to CXCR4 (Fig. 4B) .
Our data suggest a model in which agonist activation promotes rapid phosphorylation of CXCR4, most likely by a GRK (15, 18) . Phosphorylation of serine residues 324, 325, and/or 330 within the "degradation" motif may facilitate ubiquitination of neighboring lysine residue(s).
CXCR4 is most likely ubiquitinated at the plasma membrane, as it occurs in the presence of dynamin-1 K44A, an effective inhibitor of CXCR4 endocytosis. Phosphorylation of CXCR4 also promotes arrestin binding which in turn mediates CXCR4 association with clathrin-coated pits and endocytosis (15, 19) . Although difficult to directly address, our results suggest that CXCR4 ubiquitination does not interfere with arrestin binding and the subsequent targeting of the receptor to clathrin-coated pits. However, ubiquitination of CXCR4 does not appear to contribute directly to endocytosis. The endocytosed ubiquitinated receptor is subsequently sorted to a degradative pathway via interaction with additional proteins that mediate lysosomal sorting. Given the importance of CXCR4 ubiquitination in this process, we speculate that such sorting molecules might directly bind to ubiquitinated proteins and target them for lysosomal degradation. Indeed, it has recently been reported that in yeast a protein complex, known as ESCRT-1, mediates ubiquitin-dependent sorting of proteins into the multivesicular body (22) .
Our findings with CXCR4 are somewhat reminiscent of the yeast α-mating factor receptor where agonist-dependent phosphorylation mediates receptor ubiquitination, internalization, and degradation (23) . However, one clear distinction between these pathways is that while monoubiquitination is involved in endocytosis of the α-mating factor receptor (24), ubiquitination of CXCR4 is not required for internalization. This may reflect mechanistic differences in the endocytic pathways, for example, CXCR4 utilizes arrestin for endocytosis (15, 19) whereas yeast cells do not express arrestins (25). Recent studies also have shown that the δ-opioid receptor can be polyubiquitinated (26, 27). However, this appears to be agonistindependent (26) and may mediate proteosomal degradation of misfolded receptors (27).
In summary, the present study establishes a clear link between ubiquitination and degradation of CXCR4. To our knowledge this represents the first report to demonstrate that ubiquitination of a mammalian GPCR is critical for agonist dependent degradation. Our data suggest that monoubiquitination of a lysine residue within the C-terminal "degradation" motif of CXCR4 is involved in lysosomal sorting. This sorting event is likely mediated via interaction with an unidentified molecule that recognizes the monoubiquitinated form of CXCR4. Future studies will help to establish how prevalent a role ubiquitination plays in mediating agonist-promoted degradation of GPCRs. TM7 ----------------A A ---------------------------S3245A  TM7 --------------------A A -----------------------IL3289A  TM7 ----------------------A ----------------------S330A  TM7 -------------------R ---R -R ----------------- 
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